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ABSTRACT 
Objective: The objective of this study is to fabricate sodium alginate (SA)/gum ghatti (GG) microbeads intercalated with Kaolin (KA) nano clay for 
the sustained release of curcumin (CUR). 
Methods: The microbeads were prepared by a simple ionotropic gelation technique. The developed beads were characterized by fourier transform 
infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), X-ray diffraction (X-RD), and scanning 
electron microscopy (SEM). Swelling studies and in vitro release studies were investigated under both pH 7.4 and pH 1.2 at 37 °C.  
Results: The developed microbeads were characterized by FTIR, which confirms the interaction between CUR, polymeric matrix and KA. DSC and 
XRD analysis reveals that the CUR has molecularly dispersed in the polymer matrix. In vitro results illustrated that microbeads were influenced by 
the pH of test media, which might be suitable for intestinal drug delivery. The drug release mechanism was analyzed by fitting the release data into 
different kinetic equations and n values are obtained in the range of 0.609-0.640, suggesting that the developed microbeads showed the non-Fickian 
diffusion type drug release. 
Conclusion: These results clearly illustrated that the developed KA intercalated polymeric microbeads are potential drug carriers for the controlled 
release of CUR. 
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INTRODUCTION 
In today’s pharmaceutical formulations, polymers play a vital role in 
the progression of drug delivery technology by offering different 
types of pharmaceutical dosage formulations such as oral, 
parenteral, semisolid, controlled and sustained drug delivery 
systems because it can control the drug release and also it may 
increase the safety, efficacy, and bioavailability of the drugs with 
increased patient compliance [1-3]. Over the past few decades, 
polymeric interpenetrating polymer network (IPN) hydrogel 
microbeads have been broadly used as an intelligent biomaterial in 
many biomedical applications such as drug delivery and tissue 
engineering due to their excellent physical and chemical properties 
such as high water absorption tendency, high mechanical strength, 
capable of swelling under physiological conditions, providing a 
suitable environment for cell adhesion and new bone formation [4-
6]. However, hydrogels have few disadvantages such as 
unconstrained release rate and uncontrolled swelling properties, 
leading to several side effects. To overcome these problems, certain 
substances have been introduced into the hydrogels such as clay 
minerals, surface coating with other polymers such as poly-L-Lysine 
[7], chitosan [8]. By introducing clay minerals such as Kaolin, 
montmorillonite into hydrogels, this controls the release rate of 
hydrogels, minimizing side effects and maintaining the drug 
concentration at effective levels in plasma over a period of time [9]. 
During the last few years, a wide range of clay minerals have been 
used in pharmaceutical and biomedical fields exclusively for 
controlled drug delivery systems because it can control the 
efficiency and consistency in dosage formulations and also improve 
the bioavailability of the drug molecules due to their larger specific 
surface area and considerable ion-exchange capacity which 
attributes to their ability to control the efficiency of bioactive 
molecules [10-12]. Kaolin is a hydrated two-dimensional (2D) 
aluminosilicate clay mineral which has been extensively used in 
biomedical related applications such as an activating agent for blood 
clotting [13], as an ingredient for operation hemostasis [14] and also 
used in drug delivery systems for prolonged-release, especially of 
basic drugs because it can act as an active excipient in 
pharmaceutical dosage forms to increase the efficiency and 
bioavailability of drug molecules [15]. In fact their medicinal utilities 
have been discovered by many traditional civilizations (Egyptians, 
Assyrians, Babylonians, Indians, Chinese), Greeks, Romans and 
medieval Arab Muslims till the recent times [16]. 
Curcumin is a yellow bioactive compound obtained from the yellow 
spice of Curcuma longa, possesses a wide variety of pharmacological 
properties such as antibacterial, antioxidant, anti-inflammatory, anti-
malarial, antifungal antiviral and also enhances anti-tumor activity 
against different types of cancer cells, including colon, prostate and 
breast cancers [17-19]. Due to its poor solubility and rapid metabolism, 
its biomedical applications are limited which results in poor 
bioavailability [20]. To increase the bioavailability and encapsulation 
efficiency of CUR, KA clay mineral was used in the present study because 
KA intercalates with drug molecules by adsorption process, which inturn 
increases the encapsulation and bioavailability of CUR. 
Gum Ghatti (GG) is an anionic polysaccharide obtained from the 
species Anogeissus latifolia, comprising of 1→6 linked -D-
galactopyranose major units and alternating 4-O-subsituted and 2-
O-subsituted-d-mannopyranose units along with a single 
larabinofuranose unit as side chain [21, 22]. GG has widely used in 
food and pharmaceutical applications, due to its excellent 
emulsification property, many researchers have shown potential 
interest in the usage of GG in drug delivery applications as a 
controlling polymer [23]. Sodium alginate (SA) is a linear anionic 
polymer consisting of various amounts of 1→4 linked β -D-guluronic 
acid and α-L-mannuronic acid residues. SA has been commonly used 
in the food and biomedical applications due to its flexible characters 
such as biocompatible, biodegradable, inherent hydrophilicity and 
non-toxic in nature [24]. SA forms three dimensional hydrogel 
networks through the electrostatic attraction between carboxylic 
acid groups of guluronic acid residues and divalent ions (Ca2+, Mg2+ 
and Ba2+) and makes egg-box structure [25]. However, the SA 
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hydrogels have few limitations such as uncontrolled swelling 
properties and drug release profiles [26]. To overcome these 
limitations the SA polymer is blended with other polymers, grafting 
with monomers and incorporation of clay minerals [9].  
In the present research work, we focussed on the fabrication of 
SA/GG microbeads intercalated with KA. The incorporation of KA in 
the polymer matrix increases the bioavailability of CUR and also 
controls the release rate of CUR. The developed microbeads were 
characterized by different techniques such as FTIR, DSC, TGA, X-RD 
and SEM. The swelling studies and in vitro drug release kinetics were 
performed in both simulated intestinal fluid and simulated gastric 
fluid at 37 °C and the results are presented here. 
MATERIALS AND METHODS 
Materials 
Gum Ghatti and Kaolin were purchased from Sigma Aldrich (USA). 
Sodium alginate and calcium chloride were purchased from Sd. Fine 
chemicals, Mumbai, India. Curcumin was purchased from Loba 
Chemicals, Mumbai, India. Millipore water was used throughout the 
study. 
Methods 
Synthesis of SA/GG/KA microbeads 
CUR encapsulated SA/GG/KA microbeads were prepared by 
simple gelation technique [27]. SA and GG aqueous dispersions 
about 2% of each were prepared separately using millipore water. 
The blends of SA and GG were prepared by mixing varying 
amounts (i.e. 80:20, 60:40, and 40:60) in double distilled water 
and stirred well to form homogeneous mixture. To this blend 
mixture, different amounts of KA (as per given table 1) was added 
and stirred well up to formation of homogeneous mixture. Then 
required amounts of CUR was added and stirred to obtain a 
homogeneous solution. Afterwards the suspension was placed in 
sonicator for 5 min to get homogenous suspension. The resulting 
solution was added drop wise in to 5 % CaCl2
 
 solution, where the 
spherical beads formed instantly were kept for 30 min. The 
obtained wet beads were collected by decantation, washed three 
times with double distilled water to remove the drug attached on 
the bead surface, and finally were dried in air overnight at room 
temperature. A schematic diagram (fig. 1) for the preparation 
procedure is given below. 
 
Fig. 1: Schematic procedure for the preparation of CUR loaded SA/GG/KA microbeads 
 
Table 1: Formulation and composition of all samples 
Formulation code SA (w/v) GG (w/v) KA Drug (mg) 
SG1 80 20 100 100 
SG2 70 30 100 100 
SG3 60 40 100 100 
SG4 60 40 200 100 
SG5 60 40 300 100 
SG6 60 40 100 150 
SG7 60 40 100 200 




To estimate the maximum time required for intercalation of CUR 
with KA, 25 mg of CUR and 50 mg of KA was weighed and dissolved 
in 10 ml of double distilled water with continuous stirring at 37 °C. 
At regular intervals of time (15, 30, 60, 90, 120, 240 and 360 min) 
the drug solution was filtered and concentration of CUR was assayed 
using UV spectrophotometer at fixed λmax
Fourier transform infrared spectral analysis 
 value of 470.00 nm. 
Fourier transform infrared spectroscopy (FTIR) spectra of SA, GG, 
CUR, KA, placebo microbeads, and drug loaded microbeads were 
recorded with FTIR spectrophotometer (model Bomem MB-3000, 
with Horizon MBTM FTIR software) in the wavelength range of 400–
4000 cm-1
Differential scanning calorimetry (DSC) 
 to find out the possible chemical interactions between 
polymers and drug. 
DSC curves of SA, GG, CUR, KA, Placebo microbeads, and drug loaded 
microbeads were recorded using Thermogravimetry analyzer 
(Rheometric Scientific, Model DSC-SP, UK). The analysis was 
performed by heating the sample from 40 to 600 °C at a heating rate 
of 10 °C/min under nitrogen atmosphere.  
Thermogravimetric analysis (TGA) 
Thermogravimetric analysis of SA, GG, CUR, KA, Placebo microbeads, 
and drug loaded microbeads were carried out using 
Thermogravimetry analyzer Rheometric Scientific, Model DSC-SP, 
UK. About 5-7 mg of sample was placed into alumina crucible and 
the thermo grams were recorded between 40 °C to 600 °C at a 
heating rate of 10 °C/min under nitrogen atmosphere.  
X-ray diffraction (XRD)  
The X-ray diffraction of CUR, placebo microbeads, and drug loaded 
microbeads were performed by a wide angle X-ray scattering 
diffractometer (Panalytical X-ray Diffractometer, model-X’pert Pro) 
with CuKα radiation (λ= 1.54060) at a scanning rate of 10 °/min to 
determine the crystallinity. 
Scanning electron microscopy (SEM) 
The morphological characterization of microbeads was observed by 
using SEM (JOEL MODEL JSM 840A) with an accelerated voltage of 
20 kV. 
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Encapsulation efficiency 
A known mass of drug loaded microbeads (20 mg) were immersed 
into 100 ml of phosphate buffer solution (pH 7.4 containing 5 % 
absolute ethyl alcohol) for 24 h and then vigorously stirred the 
microbeads to ensure the complete extraction of CUR from the 
microbeads. Supernatants were filtered and analyzed by ultraviolet 
(UV) spectrophotometer (LabIndia, Mumbai, India) at the λmax
% EE = CUR initially added (mg)−Free CUR (mg)
CUR initially added(mg)
 x 100 
 of 
470.00 nm with placebo microbeads were used as a blank correction. 
Concentration of drug was determined by using calibration curve 
constructed by series of CUR standard solutions. Percentage of 
encapsulation efficiency was determined by the following formula. 
Swelling measurements 
The swelling behaviour of different formulations was determined 
gravimetrically in simulated intestinal fluid (pH 7.4) and simulated 
gastric fluid (pH 1.2) at 37 °C. The % of equilibrium swelling degree 
was calculated using the following equation:  
% swelling degree = Ws− W�
Wd
 x 100 
Where Ws is the weight of swollen beads and Wd
In vitro drug release studies 
 is the weight of dry 
beads. 
In vitro drug release studies of different formulations were carried out 
by using a dissolution tester (Lab India, Mumbai, India) containing 
eight baskets each with 900 ml of phosphate buffer solution (PBS) 
maintained at 37 °C, at a rotation speed of 50 rpm to replicate 
intestinal fluid (pH 7.4) and gastric fluid (pH 1.2) atmosphere 
respectively. 100 mg of the CUR loaded microbeads were taken in a 
dialysis bags for the drug release studies. At regular intervals of time, 5 
ml aliquot samples were withdrawn, and analyzed using UV 
spectrophotometer at fixed λmax
Drug release kinetics 
 value of 470.00 nm, and the released 
drug amount was obtained by using concentration versus absorbance 
calibration curves. The withdrawn aliquot samples were replenished 
with equal volumes of PBS to stimulate physiological conditions. The 
sink conditions were maintained throughout the release study. 
The drug release kinetics was analyzed by fitting the data in to 
kinetic models, which include zeroth, first order, Higuchi and 
Korsmeyer-Peppas [28-31]. Based on the goodness of data fit, the 
most suitable model was also determined [32]. 
RESULTS AND DISCUSSION 
Intercalation kinetics 
From fig. 2, it was observed that 14.51 % of CUR was intercalated 
with KA electrostatically within 90 min and remained constant up 
to 360 min. So, in the following experiments, we will keep 90 min 
time for interaction between CUR and KA to prevent partial 
interaction. 
FTIR spectral analysis 
The FTIR spectra of GG, SA, KA, CUR, placebo microbeads and drug 
loaded microbeads (SG7) are represented in fig. 3. The FTIR 
spectra of CUR shows a characteristic broad peak at 3496 cm-1, 
which corresponds to phenolic O–H stretching vibrations, a peak 
at 2923 cm-1 is assigned to aromatic C–H stretching vibrations, a 
peak at 1596 cm-1 corresponds to the stretching vibration of 
benzene ring skeleton, a peak at 1513 cm-1 corresponds to mixed 
(C=O) and (C=C) vibration, a peak at 1272 cm-1 is assigned to Ar-O 
stretching vibrations [20]. The FTIR spectra of KA shows 
characteristic peaks at 3688 and 3625 cm-1 corresponds to O–H 
stretching frequency of Si–OH and Al–OH respectively, a peak at 
3456 cm-1 assigned to H–O–H stretching frequency of interlayer 
water, peak at 2360 cm-1 was attributed to C–H stretching 
frequency, peak at 1596 cm-1 corresponds to O–H adsorbed water, 
the absorption peaks at 1126 and 902 cm-1 corresponds to Si–O–
Si stretching peak [33]. FTIR spectra of SA shows a peak at 3417 
cm-1 is responsible for O–H stretching vibrations, a peak at 1596 
cm-1 is assigned to C=O stretching vibrations, a peak at 1383 cm-1 
corresponds to COO-asymmetric stretching frequency. On 
comparing the FTIR spectra of placebo microbeads and drug 
loaded microbeads (SG7), a new peak at 1510 cm-1 was observed, 
which similar to that of C=C stretching vibration of CUR, 
suggesting that drug was present in SG7. And also the peak at 1595 
cm-1in placebo microbeads was shifted to 1592 cm-1in drug 
loaded SG7 microbeads, which confirmed that the drug interacts 
with the polymer matrix. In the case of SG7, the O–H stretching 
frequency was decreased due to the interaction of KA with active 
sites of polymer molecules and also a new peak appears at 910 cm-
1, which confirmed that the KA intercalates with active sites of 
polymer matrices and drug molecules [34]. 
 
 
Fig. 2: Effect of time for intercalation of CUR with KA 
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Fig. 3: FTIR spectrum of GG, SA, KA, CUR, placebo microbeads, and drug loaded SA/KA microbeads (SG7) 
 
Thermal analysis 
To investigate the interaction of polymer matrix with KA as well as 
the crystalline nature of encapsulated CUR in the polymer matrix, 
DSC analysis was performed and the DSC curves were displayed in 
fig. 4. The thermogram of KA shows a peak at 272 and 496 °C, 
whereas SG7 microbeads also showed similar peaks like that of KA 
at 331 and 578 °C but a slight variation was observed, which 
confirmed that the interaction takes place between active sites of the 
polymer matrix and KA [15]. The peaks in SG7 were shifted to the 
higher side due to the interaction between the polymer matrix and 
KA. DSC curve of CUR shows a sharp peak at 189 °C, whereas such a 
peak was not observed in SG7 microbeads, which confirmed that the 
drug was molecularly dispersed in the microbeads [35]. To estimate 
the thermal stability of developed microbeads TGA analysis was 
performed and the results are displayed in fig. 4. The TGA curve of 
GG showed two weight loss steps, the first weight loss step was 
observed between the regions of 40-162 °C with weight loss of 7%, 
which is due to the evaporation of water molecules adsorbed on the 
surface. The second weight loss step with a weight loss of 67% was 
found in the region of 165–600 °C, which corresponds to the 
degradation of GG polymer. The thermal decomposition of SA occurs 
in three consecutive steps. The first weight loss step with weight loss 
of 17 % was observed in the region of 40–116 °C due to the 
dehydration process. The next step was observed in the region of 
121-214 °C with a loss of 4% followed by the third step with weight 
loss of 48 % in between the region of 225-600 °C, which is due to the 
formation of sodium carbonate residue [36]. The TGA curve of CUR 
showed that the CUR should remain stable up to 168 °C, after that it 
follows mass loss and being maximum at 391 °C due to total 
degradation of the compound. In the case of KA, weight loss of 6 % 
was observed between 40 to 256 °C corresponds to the dehydration 
of water molecules absorbed in pores and between the silicate layers 
and followed by weight loss of 13% in between the region of 258-
600 °C, corresponds to the loss of structural water. The TGA curve of 
placebo microbeads showed three weight loss steps. The first weight 
loss step was found between 40-181 °C with a loss of 22 %, which is 
due to the dehydration of adsorbed water. The next two steps were 
observed in the region of 192-295 °C and 305-600 °C with a weight 
loss of 24 % and 31 %, which indicates the decomposition of the 
polymer network. In the case of drug loaded microbeads (SG7) three 
weight loss steps were observed. The first weight loss of 12 % was 
observed in the region of 42-191 °C, which is ascribed to the 
evaporation of water molecules adsorbed on the surface of 
microbeads. The second step was observed in the region of 197-313 °C 
with a loss of 20 %, followed by weight loss of 18 % in between the 
region of 321-600 °C, which corresponds to the decomposition of the 
polymer network. The TGA results suggest that the developed 
microbeads show an overall improvement in thermal stability. 
 
 
Fig. 4: Thermal analysis (A) DSC and (B) TGA 
 
X-RD analysis 
XRD analysis was performed to find out the molecular dispersion of 
CUR in the polymer matrix and the presence of KA in the 
microbeads. The diffractograms of CUR, KA, placebo and SG-7 
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microbeads were presented in fig. 5. The XRD pattern of CUR 
showed various 2Ө peaks in between 12 -28°, which is due to the 
crystalline nature of CUR. Whereas in SG-7 these peaks were not 
observed, suggesting that CUR crystalline peaks were merged with 
the polymer matrix, which indicates that the CUR changes its state 
from crystalline to amorphous nature. These results suggesting that 
the CUR has molecularly dispersed in the polymeric matrix. The XRD 
pattern of KA shows characteristic peaks at 11.95°, 18.34°, 19.97° 
and 24.84° which is due to the presence of kaolinite, the multiple 
reflection peak at 26.6° indicates the presence of quartz in kaolin 
clay. A similar observation was observed by Dewi et al. [37] from 
their characterization analysis of Kaolin. Similar peaks of KA were 
observed in the SG-7 microbeads, which indicate the presence of KA 
in the microbeads. 
 
 
Fig. 5: XRD patterns of placebo, CUR, KA and SG-7 microbeads 
 
 
Fig. 6: SEM images of placebo microbeads (a,c) and SG7 microbeads (b,d); EDS analysis of placebo microbeads (e) and SG7 microbeads (f) 
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SEM and energy-dispersive X-ray spectra (EDS) analysis 
To examine the morphological structure in the developed 
microbeads SEM analysis was performed and the results were 
displayed in fig. 6. As shown in the fig. 6, the microbeads are 
spherical having rough surfaces. On comparing the placebo 
microbeads (fig. 6a and 6c) the surface of SG-7 (fig. 6b and 6d) 
shows higher roughness, which is due to the presence of KA platelets 
on the surface of microbeads, this confirms the presence of KA in the 
microbeads. From the results of SEM images, the average size of 
microbeads was found to be 800–1500 µm. 
To investigate the elements in the microbeads EDS analysis was 
performed and the results are presented in fig. 6. The EDS spectra of 
placebo microbeads (fig. 6e) showed C, O, Al, Cl and Ca elemental 
peaks. Similar peaks were observed in SG-7 (fig. 6f), along with that 
Na, Al and Si peaks were observed, which confirms the presence of 
KA in the microbeads. These results are in good agreement with 
Reddy et al. [15] who found similar peaks of KA from their sodium 
alginate/gelatin microbeads-intercalated with kaolin nanoclay for 
controlled release of D-Penicillamine. 
Swelling measurements 
Swelling degree is one of the main factors of polymeric microbeads 
in drug delivery systems for the controlled release of drugs. Swelling 
degree experiments were carried out at pH 1.2 and 7.4 at 37 °C and 
the results were presented in fig. 7. The swelling degree results 
reveal that a higher swelling degree was observed at pH 7.4 than at 
pH 1.2 because at pH 7.4 the carboxylic groups became ionized into 
COO–
Encapsulation efficiency (% EE)  
ions, which results electrostatic repulsion between COO–
groups caused the microbeads to swell. A similar observation was 
reported by Reddy et al. [6] from their smart karaya gum/sodium 
alginate semi-IPN microbeads. Hence, the developed microbeads are 
good promising carriers to deliver drug molecules at the intestine 
and to avoid gastric release of drugs.  
The percentage of encapsulation efficiency from drug encapsulation 
studies was found to be between 43 % and 54 % (table 2). The % EE 
of CUR depends on different parameters such as % of blend 
composition, the extent of drug loading and the amount of KA. The % 
EE increased with the increase of SA content in the blend matrix, 
with increase the % of SA in blend composition, CUR-SA interactions 
increases consequently % EE increased [38]. As the % of drug 
loading is increased, % EE also increased this may be due to higher 
drug concentration, which causes entrapment of more drug 
molecules in the polymeric matrix leading to higher % EE. As the 
amount of KA increases in the polymer matrix, the % EE increased 
this is due to the formation of hydrogen bonding between free–OH 
groups of KA and CUR. 
 
 
Fig. 7: Swelling studies of Ca, CaMg, CaBa and CaAl at pH 7.4 and 
pH 1.2 at 37 °C 
 
Table 2: Encapsulation efficiency (% EE) of all samples 
S. No. Formulation code %EE 
1 SG1 47±0.8 
2 SG2 45±1.9 
3 SG3 43±1.6 
4 SG4 52±1.1 
5 SG5 54±1.5 
6 SG6 46±1.3 
7 SG7 47±1.2 
(Results are expressed as mean±SD, n=3) 
 
 
Fig. 8: In vitro release profiles of CUR microbeads at 37 °C in pH 1.2 
In vitro drug release studies 
The in vitro CUR release studies of all formulations were 
investigated under both pH 1.2 and pH 7.4 at 37 °C and the results 
are displayed in fig. 8-11. The results reveal that the percentage of 
CUR release is higher in pH 7.4 rather than pH 1.2, which is due to a 
higher pH (7.4) the carboxylate group shows less interactions with 
the buffer media, hence the network becomes slacker, therefore the 
entrapped drug molecules leached out easily from the polymer 
matrix. In vitro drug release studies for all formulations at pH 7.4 
were discussed in terms of polymer blend variation, drug variation, 
and KA variation, and the results are displayed in fig. 9 to 11. 
Effect of polymer content 
To find out the impact of polymer blend composition on % release of 
CUR was studied at a constant amount of CUR (100 mg) and KA (100 
mg). The formulations SG1, SG2 and SG3 have different polymer 
compositions and their drug release results are displayed in fig. 9. 
The results suggested SG1 showed a higher release rate than the SG2 
and SG3, this is due to SA content increases in the polymer matrix, 
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and swelling of the polymer matrix also increases due to the 
hydrophilic nature of SA. A similar observation was reported by 
Madhavi et al. [27] from their drug delivery studies of sodium 
alginate–locust bean gum IPN hydrogel beads. 
 
 
Fig. 9: Effect of polymer blend composition on % of CUR release 
at 37 °C in pH7.4 
 
Effect of KA content 
The effect of KA on the release rate of CUR was investigated by varying 
the extent of KA and the results are displayed in fig. 10. The release 
rate of SG3 (100 mg), SG4 (200 mg) and SG5 (300 mg) are 74, 72 and 
68 % respectively are displayed in fig. 10. The results suggested that 
the amount of KA increases, the drug release rate decreases. This is 
because the intercalated drug cannot be exchanged completely with 
phosphate ions in the buffer solution during the ion exchange process, 
which results incomplete release process. 
 
Fig. 10: Effect of KA content on % of CUR release at 37 °C in pH7.4 
 
Effect of drug content 
To find out the effect of drug loading on in vitro release profiles was 
studied at a constant amount of polymer blend composition and KA. 
The formulations SG3, SG6 and SG7 have different drug 
concentrations and their drug release results are displayed in fig. 11. 
The formulation SG7 showed a higher drug release rate than SG6 
and SG3. Thus the release rates vary depending upon the amount of 
drug present in the matrices i.e. release is higher for those 
formulations having a higher amount of drug and vice-versa. 
 
 
Fig. 11: Effect of drug content on % of CUR release at 37 °C in 
pH7.4 
 
Drug release kinetics 
The obtained in vitro drug release data of CUR loaded microbeads at 
pH 7.4 were fitted into different mathematical models such as zero 
order, first order and Higuchi. The release rate constant and 
correlation coefficient of all formulations are showed in table 3 and 
fig. 12. The correlation coefficient values of CUR loaded microbeads 
neither follows zero order nor first order, but the correlation 
coefficient values were close to the Higuchi model. Therefore, the 
drug release kinetics of CUR loaded microbeads follows Higuchi 
model. According to Higuchi model the release of drug from the 
microbeads, involves the penetration of liquid into the matrix and 
dissolves the drug, which then diffuses the drug into the exterior 
liquid through pores or intestinal channels. However, this type of 
phenomenon is observed in hydrophilic matrix system. Therefore 
the drug release rate of CUR loaded microbeads show the 
phenomenon of swelling and erosion of the polymer simultaneously. 
To understand the drug release mechanism, the data obtained from 
in vitro drug release studies in PBS (7.4) were fitted into the 






t is the cumulative release of CUR at time t, Mα
 
 is the total 
amount of CUR in the matrix, k is a characteristic release constant of the 
drug-polymer system and n is the release exponent indicating the type of 
drug release mechanism. The results n and k are listed in table 2. For 
spherical drug carriers, if n<0.43, the drug diffuses from the polymer 
matrix according to Fickian diffusion; if 0.43<n<0.85, anomalous or non-
Fickian type drug diffusion occurs; if n = 0.85, Case-II kinetics is 
operative; if n>0.85, the mode of drug release follows the super Case-II 
diffusion. In the present data n values are obtained in the range of 0.609-
0.640 indicates non-Fickian type of diffusion process. 
Table 3: Release kinetics parameters at pH-7.4 and encapsulation efficiency (% EE) of all samples 
Formulation code Korsmeyer-peppas Higuchi First Zero 
r n 2 r k 2 r k 2 r k 2 
SG1 0.990 0.625 0.957 18.378 0.936 0.0723 0.823 3.165 
SG2 0.986 0.628 0.970 17.565 0.941 0.0659 0.849 3.048 
SG3 0.984 0.640 0.981 17.029 0.947 0.0614 0.877 2.984 
SG4 0.972 0.638 0.988 16.677 0.945 0.0574 0.906 2.955 
SG5 0.962 0.609 0.990 16.137 0.956 0.0522 0.927 2.887 
SG6 0.981 0.634 0.976 17.405 0.947 0.0658 0.865 3.038 
SG7 0.983 0.625 0.964 17.852 0.949 0.0705 0.835 3.084 
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Fig. 12: Evaluation of drug release models in PBS 7.4 at 37 °C (A) Higuchi model (B) first order and (C) zero order 
 
CONCLUSION 
In the present study, semi-IPN microbeads were fabricated from 
SA/GG intercalated with KA by a simple ionotropic technique. 
Microbeads formation was confirmed by FTIR spectroscopy. DSC 
and X-RD confirm the molecular level dispersion of CUR into 
microbeads. Morphological studies reveal that the microbeads were 
spherical in shape with a rough surface. From the SEM studies, the 
average diameter of microbeads was found to be 800–1500 µm. 
Results of the swelling and in vitro release studies confirm that the 
fabricated microbeads are suitable for interstitial drug delivery. In 
vitro releases studies fitted into the Peppas equation and followed 
the non-Fickian diffusion transport. Based on the results, it was 
suggesting that the developed microbeads were potentially good 
carriers for the controlled release of CUR.  
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